Security key
426897104
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897104
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 29,123,952
- Total 13F shares
- 5,465,996
- Share change
- +4,276,553
- Total reported value
- $11,970,665
- Put/Call ratio
- 101%
- Price per share
- $2.19
- Number of holders
- 28
- Value change
- +$9,227,790
- Number of buys
- 26
- Number of sells
- 7
Report period
Q4 2020
Institutions
28
Top holders
10
HEPA full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897104
Recent filing periods:
Top shareholders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
0.21%
|
60,636
|
$189,000 | — | 30 Sep 2020 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
57,309
|
$178,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
33,210
|
$103,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
29,233
|
$91,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
20,312
|
$63,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
15,786
|
$49,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.05%
|
15,552
|
$48,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
15,524
|
$48,000 | — | 30 Sep 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
11,632
|
$36,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
4,519
|
$14,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
2,500
|
$8,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,591
|
$5,000 | — | 30 Sep 2020 |
Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q4 2020
As of 31 Dec 2020,
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,465,996 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., AIGH Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, Squarepoint Ops LLC, Schonfeld Strategic Advisors LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
12
Q4 2020 holders
28
Holder diff
16
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.